Form 8-K ImmunoCellular Therapeut For: May 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall Street ends choppy session lower as tech shares drop
- Meta Platforms stock surges 8% on cloud business plans
- Humanoid robot component stocks surge on supply-chain optimism
- Oil prices fall 1% to 4-month lows as progress in US-Iran talks cools supply concerns
- Trump discloses over $1.4 billion in crypto income in 2025 filing
ImmunoCellular Therapeutics (IMUC) Tops Q1 EPS by 1c
May 12, 2016 4:59 PM EDTImmunoCellular Therapeutics (NYSE: IMUC) reported Q1 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on ImmunoCellular Therapeutics (IMUC) click here.
... More
